Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-115071
Filing Date
2025-11-21
Accepted
2025-11-21 18:13:11
Documents
1
Period of Report
2025-11-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2531988-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2531988-1_4seq1.xml 4 3855
  Complete submission text file 0001104659-25-115071.txt   5399
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Issuer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SAGIMET BIOSCIENCES INC. 155 BOVET RD., STE. 303 SAN MATEO CA 94402
Business Address
Kemble George (Reporting) CIK: 0001858176 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41742 | Film No.: 251509228